Care for patients with rheumatic diseases during COVID-19 pandemic: A position statement from APLAR

Int J Rheum Dis. 2020 Jun;23(6):717-722. doi: 10.1111/1756-185X.13863. Epub 2020 May 27.

¹ Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China.
² The First Department of Internal Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan.
³ Apollo Indraprastha Hospitals, New Delhi, India.
⁴ Division of Allergy, Immunology and Rheumatology, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
⁵ Allergy, Arthritis & Rheumatism Clinic, Farrer Park Hospital, Singapore City, Singapore.
⁶ Yong Loo Lin School of Medicine, National University of Singapore, Singapore City, Singapore.
⁷ Deptartment of Rheumatology, BSMMU, Dhaka, Bangladesh.
⁸ Department of Rheumatology, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Peking Union Medical College & Chinese Academy of Medical Science, Peking Union Medical College Hospital, National Clinical Research Center for Dermatologic and Immunologic Diseases, Ministry of Science & Technology, Beijing, China.
⁹ Makati Medical Center, Makati, Philippines.
¹⁰ Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea.
¹¹ Laboratory for Autoimmune Diseases, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
¹² BSM Medical University, Dhaka, Bangladesh.

No abstract available

Publication types